Literature DB >> 7438385

Effect of naloxone, a specific opioid inhibitor, on blood pressure fall during sleep.

P Rubin, T F Blaschke, C Guilleminault.   

Abstract

The study was designed to investigate the possible role of endogenous opioids in the fall in blood pressure (BP) seen during initial sleep. Seven normal men, ages 20-30 years, were studied for three consecutive nights. Each night, electroencephalogram, chin electromyogram, electrooculogram, heart rate (all continuously), and blood pressure (every 15 minutes) were recorded. Night 1 was used for orientation. On nights 2 and 3, subjects received, in randomized order, an infusion of naloxone 0.2 mg/kg over 1 minute or volume-matched saline. Blood pressure data from the first 4 hours of non-rapid eye movement sleep were combined. On the placebo night, systolic BP fell from 114.6 +/- 6 mm Hg to 103.7 +/- 8 mm Hg (+/- SD) (p < 0.05, Wilcoxon rank-sum test). On the naloxone night, systolic BP did not change. Neither diastolic BP nor heart rate were influenced by naloxone. these data suggest that endogenous opioids could be involved in the fall in systolic BP seen during initial sleep.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7438385     DOI: 10.1161/01.cir.63.1.117

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities.

Authors:  Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

Review 2.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  The influence of naloxone on the circulatory effects of captopril.

Authors:  P C Rubin; J A Millar; S Sturani; C Lawrie; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

4.  Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity.

Authors:  J Słowinska-Srzednicka; S Zgliczynski; P Soszynski; J Puciłowska; M Wierzbicki; W Jeske
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 5.  Diabetes and arterial hypertension.

Authors:  P L Drury
Journal:  Diabetologia       Date:  1983-01       Impact factor: 10.122

6.  Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers.

Authors:  James P Zacny; Kristen Wroblewski; Dennis W Coalson
Journal:  Psychopharmacology (Berl)       Date:  2014-05-29       Impact factor: 4.530

7.  Naloxone-provoked vaso-vagal response to head-up tilt in men.

Authors:  P Madsen; M Klokker; H L Olesen; N H Secher
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

8.  Naloxone does not antagonize the antihypertensive effect of chronic captopril therapy in hypertensive patients.

Authors:  G P Bernini; A R Lucarini; M S Vivaldi; C Del Corso; M Lenzi; A Salvetti
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.